Results for tag: "Chemokine Receptor"

The Chemokine Receptor market is a subset of the Immune Disorders Drugs market. Chemokine Receptors are proteins that bind to chemokines, which are small proteins that regulate the movement of cells in the immune system. Chemokine Receptor drugs are used to treat a variety of immune disorders, including asthma, rheumatoid arthritis, and multiple sclerosis. These drugs work by blocking the binding of chemokines to their receptors, thus preventing the movement of cells in the immune system. This can reduce inflammation and improve the symptoms of the disorder. Chemokine Receptor drugs are typically administered orally or intravenously. They are often used in combination with other drugs, such as corticosteroids, to maximize their effectiveness. The market for Chemokine Receptor drugs is growing, as more people are being diagnosed with immune disorders. Some companies in the Chemokine Receptor market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more